the aid library

LIST OPTIONS

Filter

7816

The future of WHO Covid-19 response operations in Africa in 2022
recommended

World Health Organization WHO, Regional Office of Africa (2022) C_WHO

The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC) attainment.

Download (465)

View PDF (893)

India: Integrated Management of Neonatal and Childhood Illness (f-IMNCI) - Participant's Manual (Module 1/9)

Ministry of Health and Family Welfare, Government of India; WHO; UNICEF (2009) C_WHO

Download (265)

View PDF (435)

How Covid-19 is changing the world: a statistical perspective

UN DESA (2020) CC

COVID-19 has turned the world upside down. Everything has been impacted. How we live and interact with each other, how we work and communicate, how we move around and travel. Every aspect of our lives has been affected.

Download (282)

View PDF (263)

Covid-19 pandemic impact on maternal and child health services access in Nampula, Mozambique: a mixed methods research

das Neves Martins Pires P.H. , Macaringue C. , Abdirazak A. et al. BMC Health Services (2021) CC

The Covid-19 pandemic has so far infected more than 30 million people in the world, having major impact on global health with collateral damage. In Mozambique, a public state of emergency was declared at the end of March 2020. This has limited people's movements and reduced public services, leading ...to a decrease in the number of people accessing health care facilities. An implementation research project, The Alert Community for a Prepared Hospital, has been promoting access to maternal and child health care, in Natikiri, Nampula, for the last four years. Nampula has the second highest incidence of Covid-19. The purpose of this study is to assess the impact of Covid-19 pandemic Government restrictions on access to maternal and child healthcare services. We compared health centres in Nampula city with healthcare centres in our research catchment area. We wanted to see if our previous research interventions have led to a more resilient response from the community. METHODS: Mixed-methods research, descriptive, cross-sectional, retrospective, using a review of patient visit documentation. We compared maternal and child health care unit statistical indicators from March-May 2019 to the same time-period in 2020. We tested for significant changes in access to maternal and child health services, using KrushKall Wallis, One-way Anova and mean and standard deviation tests. We compared interviews with health professionals, traditional birth attendants and patients in the two areas. We gathered data from a comparable city health centre and the main city referral hospital. The Marrere health centre and Marrere General Hospital were the two Alert Community for a Prepared Hospital intervention sites. RESULTS: Comparing 2019 quantitative maternal health services access indicators with those from 2020, showed decreases in most important indicators: family planning visits and elective C-sections dropped 28%; first antenatal visit occurring in the first trimester dropped 26%; hospital deliveries dropped a statistically significant 4% (p = 0.046), while home deliveries rose 74%; children vaccinated down 20%. CONCLUSION: Our results demonstrated the negative collateral effects of Covid-19 pandemic Government restrictions, on access to maternal and child healthcare services, and highlighted the need to improve the health information system in Mozambique. more

Download (217)

View PDF (341)

UNICEF Central African Republic COVID-19 Situation Report No.10 reporting period November – December 2020

UN Children's Fund UNICEF (2021) C_UNICEF

Download (247)

View PDF (372)

Информирование о рисках и взаимодействие с населением при отслеживании контактов больных COVID-19

World Health Organization WHO (2021) C_WHO

Contact tracing is a key element of WHO’s recommended approach to control the spread of COVID-19 by breaking the chains of human-to-human transmission. This document provides guidance to health authorities at all levels to improve the success rate of contact tracing by informing efforts with RCCE... more

Download (197)

View PDF (342)

Guia sobre direitos sexuais e reprodutivos das mulheres durante a pandemia da COVID-19

Defensoria Pública do Estado de São Paulo (2020) C2

Guia sobre direitos sexuais e reprodutivos das mulheres durante a pandemia da COVID-19 - Contracepção, aborto legal, gestação, parto e pós-parto

Download (850)

View PDF (676)

Integrated Management of Neonatal and Childhood Illness - Introduction (Module 1/9)

Ministry of Health and Family Welfare, Government of India; WHO; UNICEF (2009) C_WHO

Download (228)

View PDF (410)

Zimbabwe Humanitarian Response Plan 2020 (Revised July 2020 to update COVID-19 Response)

UN Office for the Coordination of Humanitarian Affairs OCHA (2020) C1

Across Zimbabwe, 7 million people in urban and rural areas are in urgent need of humanitarian assistance, compared to 5.5 million in August 2019. Since the launch of the Revised Humanitarian Appeal in August 2019, circumstances for millions of Zimbabweans have worsened. Drought and crop failure, exa... more

Download (275)

View PDF (305)

COVAXIN® (BBV152) – Inactivated, COVID-19 vaccine

World Health Organization WHO (2022) C_WHO

The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.

Download (301)

View PDF (654)

COVID-19 Preparedenss Checklist for rural primary health care & community settings

The Georg Institute for Global Health India (2020) C1

Download (279)

View PDF (303)

CARE Rapid Gender Analysis of COVID-19 in Myanmar

CARE (2020) CC

7 June 2020 Version 1 Women in Myanmar have traditionally been underrepresented in public decision-making processes, a trend which is continuing in structures established to respond to COVID-19. This means that even as women are disproportionately affected by the crisis, they have less say in how t... more

Download (302)

View PDF (261)

Best Practices and Experience of Mauritius Preparedness and Response to COVID-19 Pandemic

World Health Organization WHO; Regional Office for Africa, Government of Mauritius (2021) C_WHO

his Inter Action Review report for the COVID-19 outbreak in Mauritius documents and assesses the country’s capacity to respond to the outbreak and identifies the best practices, strengths, gaps and challenges of the national response. Areas requiring improvements or sustained actions have been ide... more

Download (279)

View PDF (334)

Considerations and Principles for Shielding People at High Risk of Severe Outcomes from COVID-19

Social Science in Humanitarian Action (2020) CC

This brief considers the rationale for shielding individuals at high risk of severe disease or death from COVID-19 in low- and middleincome countries. It provides an overview of proposed approaches to shielding, discusses the categories of individuals who may be identified for shielding, and outline... more

Download (765)

View PDF (862)

National Guidelines for Quality Improvement of HIV and AIDS Services

Ministry of Health and Social Welfare, National AIDS Control Programme, Tanzania (2010) C1

Download (305)

View PDF (392)

Towards transformative integration of the HIV and AIDS response into universal health coverage: Building on the strengths and successes of the HIV and AIDS response

G. Ooms; K. Kruja; M. Hart; D. Ruiz Aidsfonds; PITCH (Partnership to Inspire, Transform and Connect the HIV response) (2019) C2

Experiences from Indonesia, Kenya, Uganda and Ukraine

Download (356)

View PDF (290)

Direct and indirect effects of COVID-19 on maternal and child health in Bangladesh

M. M. Ahmmed; M. A. Babu; J. Ferdosy (2021) CC

Bangladesh has been going through incremental trend of GDP growth rates for a long time. The GDP is the key aspect to measure the economic growth of a country. But the current world wide pandemic due to the COVID-19 hardly affects the world’s economy as well as Bangladesh. The present... more

Download (466)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

COVID-19 in Malawi: lessons in pandemic preparedness from a tertiary children’s hospital

Chaziya J, Freyne B, Lissauer S et al. (2021) CC

Archives of Disease in Childhood 2021;106:238-240.

Download (379)

View PDF (464)

Atlas of Common Clinical Presentations of Paediatric HIV Infections

Ministry of Health Uganda (2016) C2

Over 2 million children worldwide are living with HIV infection and 95% reside in sub-Saharan Africa with the majority infected through mother-to-child transmission. Infected children have a high mortality with 50% dying by 2 years of age. Their clinical presentation includes common childhood infect... more

The future of WHO Covid-19 response operations in Africa in 2022 recommended

The future of WHO Covid-19 response operations in Africa in 2022
recommended